Azaplast 100mg Injection

Azacitidine (100mg) Primary uses of : Ovarian cancer, Head and neck cancer, Cervical cancer
Manufacturer: RPG Life Sciences Ltd
₹ 8,500.00 incl tax
Expert advice for Azaplast Injection • You will be treated with drugs to prevent nausea and vomiting at the start of azacitidine treatment cycle. • You will be monitored with lab test to measure complete blood count before every treatment cycle to check development of anemia (low red blood count), neutropenia (abnormally low white blood cell count) or thrombocytopenia (abnormally low count of platelets in the blood). • Take extreme care to avoid pregnancy while on azacitidine therapy. • Inform your doctor if you have a history of congestive heart failure, unstable heart or lung disease. • Seek immediate medical attention if you experience difficulty in breathing, swelling of the lips, itching or rash. • Patients allergic to azacitidine or any of its ingredients should not be administered this. • Patients with advanced malignant liver cancer should not be given azacitidine. • Pregnant and breastfeeding women should also not be given azacitidine. • Children and adolescents below 18 years should not be given azacitidine.
Composition Azacitidine (100mg)
Potentially Unsafe With Lactation
Side Effect Common Headache, Dizziness, Insomnia (difficulty in sleeping), Vomiting, Nausea, Decreased potassium level in blood, Loss of appetite, Decreased white blood cell count, Nasopharyngitis (inflammation of the throat and nasal passages), Anemia (low number of red blood cells), Diarrhoea, Febrile neutropenia, Decreased white blood cell count (neutrophils), Constipation.
How to works How Azaplast Injection works Azaplast 100mg Injection interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.